CNBC Events

APRIL 16✨ Join us in NYC for the #CNBCChangemakers Summit! Hear from female leaders who've navigated hurdles & turned setbacks into major opportunities📈💰 Come be inspired to lead, innovate & drive change✨✨ Get your ticket here: bit.ly/4b9hQeX

JUST ANNOUNCED: Check out the latest speakers joining the lineup for the #InvestInAmericaForum in D.C.! @SaraEisen will sit down with these CEO's to talk what's working and what's not when it comes to American economic and industrial policies. LEARN MORE: bit.ly/4b3wfJy

LAST CHANCE⏰ Snag your discounted ticket for the Changemakers Summit TODAY bc early bird rate ends tonight! Hear from women who are creating multibillion-dollar brands, breaking down barriers & driving change. #CNBCChangemakers Lock in your deal here → bit.ly/4b9hQeX

THIS THURSDAY → Don't miss the CNBC CURES: DEFYING RARE DISEASE premiering on CNBC at 7pm ET! Watch the most influential investors, policy makers and leaders in biotechnology come together to accelerate the future of medicine through breakthroughs in rare disease research.

NYC🏙️ Join us for the CNBC Changemakers Summit, a women's leadership summit, bringing together #CNBCChangemakers to talk about how they've navigated hurdles & turned setbacks into major opportunities📈 Come be inspired to lead, innovate & drive change✨👉 bit.ly/4b9hQeX

APRIL 15 → @SaraEisen hosts the #InvestInAmericaForum in D.C., convening global financial leaders to talk this past year of economic and industrial policymaking and how its impacting American companies. Learn more & join us: bit.ly/4b3wfJy

We're excited to announce new speakers for the CNBC Changemakers Summit! @JBoorstin will sit down with these leaders who are driving innovation and building businesses poised for sustainable success. Learn more and join us at #CNBCChangemakers! MORE: bit.ly/4aFX5po

The rare disease community is unlike anything I’ve seen before. Truly a different breed of operators. Many of the players in the ecosystem from biotech executives to patient advocates are also parents, siblings, or relatives of someone living with a rare disease. In an otherwise commercially driven industry, the drive to find treatments is deeply personal and altruistic. They are simply not prepared to take no for an answer. Thank you to @BeckyQuick and @cnbcevents for bringing this community together. #CNBCCures @MendraInc

President Tiara Green and EVP of Development and Growth, Alan Wood, attended the inaugural @cnbcevents Cures Summit, a landmark live event bringing together the most influential investors, policy makers and leaders in biotechnology to accelerate the future of medicine through breakthroughs in rare disease research. Accessia Health's attendance reflects our commitment to actively engaging in conversations shaping the future of healthcare delivery, unlocking innovative funding models, and building a future where scientific breakthroughs translate into real-world impact for individuals and families navigating rare and complex conditions. #AccessiaHealth #PatientAssistance #CNBCCuresSummit

Our President & CEO Neil McFarlane attended the inaugural CNBC Cures Summit to advance solutions accelerating rare disease innovation. The call to remove barriers & drive meaningful change aligns with Zevra’s commitment to the rare disease community. #RareDisease #CNBCCures

At @CNBC Cures today, we heard a powerful reminder of why so many of us have stayed in this field for decades: patients. The books below from @AlexionPharma highlight rare disease stories — a testament to the real people at the center of every scientific discovery and policy debate. Appreciate Tamar Thompson and the Alexion team for helping elevate these voices. #CNBCCures #RareDisease

The FDA approved 20 drugs via the Accelerated Approval pathway in 2024—in 2025 the FDA only approved 9 drugs via accelerated approval said Gottlieb #cnbccures $XBI $BBC $IBB @cnbcevents @cnbc

The FDA's oncology drugs review staff is down to <60. It used to be 100 said @ScottGottliebMD on panel at #CNBCCures moderated by @BeckyQuick. HIgh # of senior reviewers are gone & v difficult to replace. Will probably see a higher # of CRLs in '26 he said. $XBI $BBC $IBB @cnbcevents

WATCH NOW: The CNBC Cures Summit is LIVE cnbc.com/cures-events #CNBCCures

Headed to @CNBC Cures today. Looking forward to conversations about the next wave of medical innovation – and what it will take to ensure patients can access new treatments quickly and sustainably. @cnbcevents #CNBCCures #PatientAccess

WATCH the CNBC Cures Summit LIVE: cnbc.com/cures-events #CNBCCures

@cnbcevents @BeckyQuick When I was born, there was no treatment. Today, there is. That’s why March 3 matters.

TODAY→ Key leaders convene at the #CNBCCures Summit to discuss the issues blocking medical progress for the #raredisease community and provide actionable insight into what can be done to fix these problems. Watch the Summit via a free livestream→ bit.ly/3MzlpBm

TOMORROW→ @BeckyQuick talks about the uncomfortable truth about how rare disease cures only get funded at scale when the economics work at #CNBCCures. Hear why this happens, what needs to change & the new models being developed to fix this. MORE: bit.ly/3LoiQ4v

Join us on the livestream for our first CNBC Cures conference Tuesday, March 3! cnbcevents.com/cures